— Know what they know.
Not Investment Advice

INVA NASDAQ

Innoviva, Inc.
1W: -2.9% 1M: -5.5% 3M: -5.1% YTD: +11.7% 1Y: +18.2% 3Y: +67.5% 5Y: +72.5%
$22.46
+0.26 (+1.17%)
 
Weekly Expected Move ±3.1%
$21 $21 $22 $23 $23
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 34 · $1.7B mcap · 69M float · 1.05% daily turnover · Short 44% of daily vol

Balance Sheet Trends

Total Assets
$1.6B +25.7% ▲
5Y CAGR: +10.3%
Total Liabilities
$462M -24.2% ▼
5Y CAGR: +3.4%
Shareholders Equity
$1.2B +69.7% ▲
5Y CAGR: +16.8%
Cash & Investments
$551M +33.6% ▲
5Y CAGR: +17.5%
Total Debt
$269M -40.4% ▼
5Y CAGR: -6.9%
Net Debt
-$282M -292.9% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$202M$291M$194M$305M$551M
Short-Term Investments$0$0$0$108M$0
Cash & ST Investments$202M$291M$194M$412M$551M
Net Receivables$111M$64M$84M$86M$35M
Inventory$0$56M$41M$34M$39M
Other Current Assets$70K$3M$4M$656K$102M
Total Current Assets$314M$444M$344M$554M$728M
Property, Plant & Equip.$109K$3M$3M$3M$12M
Goodwill & Intangibles$0$280M$248M$226M$200M
Long-Term Investments$484M$403M$561M$394M$194M
Other Non-Current Assets$129M$102M$87M$111M$501M
Total Non-Current Assets$613M$788M$899M$747M$908M
Total Assets$926M$1.2B$1.2B$1.3B$1.6B
— Liabilities —
Accounts Payable$27K$3M$7M$2M$5M
Short-Term Debt$0$96M$0$192M$418K
Deferred Revenue$0$2M$1M$1M$4M
Other Current Liabilities$0$3M$0$6M$40M
Total Current Liabilities$6M$135M$38M$236M$50M
Long-Term Debt$395M$444M$446M$256M$258M
Other Non-Current Liab.$1$78M$82M$116M$112M
Total Non-Current Liabilities$395M$531M$530M$374M$413M
Total Liabilities$400M$666M$569M$610M$462M
— Equity —
Common Stock$696K$692K$633K$627K$747K
Retained Earnings-$456M-$205M-$25M-$2M$269M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$415M$566M$675M$691M$1.2B
Total Liabilities & Equity$926M$1.2B$1.2B$1.3B$1.6B
— Key Metrics —
Total Debt$395M$544M$449M$451M$269M
Net Debt$193M$253M$256M$146M-$282M
Total Investments$484M$403M$561M$501M$194M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms